Abstract
Introduction
The latest American College of Cardiology and American Heart Association (ACC/AHA) Guidelines for high blood pressure in adults bring changes with lower cut-off points, creating socioeconomic issues in low and middle income countries. It is necessary to consider the changes that would have the adherence to these new guidelines in diagnosis and hypertension (HTN) control with ambulatory blood pressure monitoring (ABPM), the gold standard for hypertension diagnosis.
Aim
To describe the changes in hypertension diagnosis and control according to the latest ACC/AHA guidelines, the European Society of Cardiology and European Society of Hypertension (ESC/ESH) and Latin-America Society of Hypertension (LASH) guidelines.
Methods
Cross-sectional, descriptive, retrospective study of all patients who have had an ABPM during June 2017 and June 2018 according to cut-off points established by the ACC/AHA Guidelines compared to the ESC/LASH Guidelines.
Results
1957 patients evaluated with ABPM were included; median age was 57 years, 55% were female. The difference in diagnosis by 24-h ABPM, day-time, and night-time cycle was 21%, 42%, and 24% higher applying ACC/AHA guidelines vs ESC/ESH guidelines. There were no significant differences regarding the history of HTN, gender, and age in the circadian pattern.
Conclusion
If the measured value of blood pressure in the 24-h ABPM is taken into account, it would necessary to intervene pharmacologically 21.5% more individuals according to the ACC/AHA guidelines in our population, Individualization is awarded.
Similar content being viewed by others
References
Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet. 2014;383(9932):1899–911.
Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD, DePalma SM, et al. 2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk. J Am Coll Cardiol. 2017;70(14):1785–822.
National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES): examination manuals 2011–2012, 2013–2014.
Camacho PA, Gomez-Arbelaez D, Molina DI, Sanchez G, Arcos E, Narvaez C, et al. Social disparities explain differences in hypertension prevalence, detection and control in Colombia: J Hypertens. 2016;34(12):2344–52.
Williams B, Mancia G. Ten commandments of the 2018 ESC/ESH HTN guidelines on hypertension in adults. Eur Heart J. 2018;39(33):3007–8.
Sociedad Colombiana de Cardiología, Fundación Colombiana del Corazón, Fondo Colombiano de Enfermedades de Alto Costo. Boletín de Información Técnica Especializada de la Cuenta de Alto Costo (internet). 2018 pp. 1–8. Report no.: volumen 4, número 08. https://cuentadealtocosto.org/site/images/Publicaciones/boletines/2018/CAC.Co_2018_05_16_BolTec_V4N08_DM_Hipertension_v.0.0.pdf
Lee JH, Kim S-H, Kang S-H, Cho JH, Cho Y, Oh I-Y, et al. Blood pressure control and cardiovascular outcomes: real-world implications of the 2017 ACC/AHA hypertension guideline. Sci Rep. 2018;8(1):13155.
Garies S, Hao S, McBrien K, Williamson T, Peng M, Khan NA, et al. Prevalence of hypertension, treatment, and blood pressure targets in Canada associated with the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines. JAMA Netw Open. 2019;2(3):e190406.
López-Jaramillo P, López-López J, Forero-Trillos MF, Rueda-Quijano SM, Camacho PA, Esmeral-Ordoñez D, et al. Repercutirán las nuevas cifras de las guías AHA/ACC en la definición y manejo de la hipertensión en Latinoamérica? Hipertens Riesgo Vasc. 2019.
Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J. Estimating the association of the 2017 and 2014 hypertension guidelines with cardiovascular events and deaths in US adults: an analysis of national data. JAMA Cardiol. 2018;3(7):572.
Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, et al. Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial. Ann Intern Med. 2017;167(6):375.
Funding
This research did not receive any specifc grant from funding agencies in the public, commercial, or not-for-proft sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All the authors declares that they have no confict of interest.
Rights and permissions
About this article
Cite this article
Giraldo-Gonzalez, G.C., Victoria, A.M. & Vesga, C.E. Hypertension prevalence in Colombian Patients Evaluated with Ambulatory Blood Pressure Monitoring According to Changes in Clinical Guidelines Between 2017–2018. High Blood Press Cardiovasc Prev 27, 309–313 (2020). https://doi.org/10.1007/s40292-020-00387-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-020-00387-w